Advocacy

Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria

September 2017 Continued Discussions : Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria BioMelbourne Network convened a roundtable with Minister Wade Noonan, Minister Philip Dalidakis and 14 pharmaceutical and biotechnology companies who currently manufacture or develop products for manufacture…

Read More

Joint Statement on Skilled Migration Visa Changes

July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…

Read More

BioMelbourne Network Welcomes Revisions to Skilled Migration Visas

July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…

Read More

Department of Immigration Roundtable Discussion (May 2017)

BioMelbourne Network CEO, Dr Krystal Evans attended a technology industries roundtable discussion with the Department of Immigration and the Department of Industry regarding skilled migration and the decision to abolish the 457 visa program. The medical technology, biotechnology and…

Read More

Joint statement on the Research & Development Tax Incentive (April 2017)

18 April 2017 Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research &…

Read More

Changes to the R&D Tax Incentive: Putting a handbrake on innovation (September 2016)

September 2016 The R&D Tax Incentive Review paper was released on 28th of September, making recommendations on changes to the scheme – including a proposed $2Million cap on the annual cash refund payable under the R&D Tax Incentive.…

Read More

BioMelbourne Network CEO on MELBOURNE 4.0 Steering Committee

September 2015 The Committee for Melbourne has announced the members of the MELBOURNE 4.0 Steering Committee. The Steering Committee will drive the MELBOURNE 4.0 engagement process and ensure concrete policy initiatives are identified. Reflective of the Committee for…

Read More

MTP Connect Competitiveness Plan Consultation Lunch (September 2016)

September 2016 A new pathway for engagement with the Federal Government on issues concerning the sector is through the recently established  Industry Growth Centres. Last week, BioMelbourne Network held a CEO lunch with Sue MacLeman, CEO MTPConnect as…

Read More

Nature 2016 Research Translation and Innovation Symposium (August 2016)

August 2016 Leadership | Culture | Communication | Collaboration | Human Capital | Scale These were the strong themes emerging from the Nature 2016 Research Translation and Innovation Symposium held in Canberra last week on Thursday 11th of…

Read More

10 year sector competitiveness plan for Medical Technologies and Pharmaceuticals

August 2016 We want to know if we’ve got it right, said Sue MacLeman, CEO of MTPConnect at the launch of the 10 year Sector Competitiveness Plan – which is still in draft form. The plan outlines seven…

Read More

Launch Vic Collaboration (July 2016)

July 2016 BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch…

Read More

Meeting with the Hon Wade Noonan MP

July 2016 BioMelbourne Network CEO, Dr Krystal Evans and Chair, Mr Andrew Carter held an introductory meeting with the Hon Wade Noonan, Minister for Industry and Employment. Minister Noonan was appointed into this role in May and has…

Read More

Home

News & opinion

Member Directory

Events